0000929638-23-002511.txt : 20230912
0000929638-23-002511.hdr.sgml : 20230912
20230912200956
ACCESSION NUMBER: 0000929638-23-002511
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230831
FILED AS OF DATE: 20230912
DATE AS OF CHANGE: 20230912
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baron Caryl
CENTRAL INDEX KEY: 0001949735
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39927
FILM NUMBER: 231251358
MAIL ADDRESS:
STREET 1: C/O SEASTAR MEDICAL, INC.
STREET 2: 3513 BRIGHTON BOULEVARD, SUITE 410
CITY: DENVER
STATE: CO
ZIP: 80216
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SeaStar Medical Holding Corp
CENTRAL INDEX KEY: 0001831868
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 853681132
STATE OF INCORPORATION: CO
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3513 BRIGHTON BLVD
STREET 2: SUITE 410
CITY: DENVER
STATE: CO
ZIP: 80216
BUSINESS PHONE: 844-427-8100
MAIL ADDRESS:
STREET 1: 3513 BRIGHTON BLVD
STREET 2: SUITE 410
CITY: DENVER
STATE: CO
ZIP: 80216
FORMER COMPANY:
FORMER CONFORMED NAME: LMF Acquisition Opportunities Inc
DATE OF NAME CHANGE: 20201109
4
1
form4.xml
X0508
4
2023-08-31
0001831868
SeaStar Medical Holding Corp
ICU
0001949735
Baron Caryl
C/O SEASTAR MEDICAL HOLDING CORPORATION
3513 BRIGHTON BLVD., SUITE 410
DENVER
CO
80216
true
Interim CFO
false
Common Stock, par value $0.0001 per share
2023-08-31
4
A
0
3374
0
A
100396
D
Stock Option (Right to Buy)
1.84
2033-04-06
Common Stock
16621
16621
D
Stock Option (Right to Buy)
10
2030-03-20
Common Stock
4796
4796
D
Stock Option (Right to Buy)
0.55
2031-01-01
Common Stock
19685
19685
D
The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee.
All options reported herein will vest, subject to continued service, on April 6, 2024.
The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from March 30, 2020 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from March 30, 2021.
The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from January 1, 2021 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from January 1, 2022.
/s/ Eric Schlorff, as attorney-in-fact
2023-09-12